Shop ES Congenital Adrenal Hyperplasia ... Steroid 21-Hydroxylase Deficiency

Congenital Adrenal Hyperplasia Due to Steroid 21-Hydroxylase Deficiency

Published: September 2018
$9.95
Print Copy Information:
  • 18 pages
  • Spiral Bound
  • 80# Aqueous Coating
  • 4.25" x 7.25"
  • Ships in 5 – 10 business days
Add to Cart
What's Inside
Bulk and Institutional Ordering
About the Authors
Additional Information
  • Key Points
  • Diagnosis
    • Newborn Screening
    • Diagnosis of Congenital Adrenal Hyperplasia
  • Treatment
    • Prenatal Treatment of Congenital Adrenal Hyperplasia
    • Treatment of Classic Congenital Adrenal Hyperplasia
    • Treatment of Nonclassic Congenital Adrenal Hyperplasia
    • Long-Term Management of Patients With Congenital Adrenal Hyperplasia
    • Restoring Functional Anatomy By Surgery in Individuals With Congenital Adrenal Hyperplasia
    • Experimental Therapies and Future Directions
    • Mental Health
  • Tables
    • Comparative Incidence of Classic CAH in Different Populations
    • Maintenance Therapy in Growing Patients with CAH
    • Maintenance Therapy Suggested in Fully Grown Patients
    • Suggested Stress Doses of GC for Adrenal Crisis
    • Utility of Various Analytes for Monitoring CAH Treatment
  • Figures
    • Fetal Adrenal Steroidogenesis
    • Diagnosis of 21OHD
    • Lower Urogenital Anatomy of Mild and Severe CAH
    • Partial Urogenital Mobilization with Separation of the Urethra and Vagina
  • For purchases under 100 in quantity, we suggest placing the order directly through the website.
  • We offer group/institutional licenses for multi-user accounts (discount amount varies depending on the number of users).
  • We are proud to offer special discounts to medical schools, training programs, students and more.
  • We offer bulk purchase discounts based on number of copies and number of titles.

Contact Us for more details

Founded in 1916, The Endocrine Society is the world's oldest, largest, and most active organization devoted to research on hormones and the clinical practice of endocrinology. The Society works to foster a greater understanding of endocrinology amongst the general public and practitioners of complementary medical disciplines and to promote the interests of all endocrinologists at the national scientific research and health policy levels of government. The Hormone Foundation, the Society's public education affiliate, is a leading source of hormone-related health information for the public, physicians, allied health professionals and the media.

Description

This resource is for informational purposes only, intended as a quick-reference tool based on the cited source guideline(s), and should not be used as a substitute for the independent professional judgment of healthcare providers. Practice guidelines are unable to account for every individual variation among patients or take the place of clinician judgment, and the ultimate decision concerning the propriety of any course of conduct must be made by healthcare providers after consideration of each individual patient situation. Guideline Central does not endorse any specific guideline(s) or guideline recommendations and has not independently verified the accuracy hereof. Any use of this resource or any other Guideline Central resources is strictly voluntary.

You can also find this product included in this bundle!

ES Guidelines Bundle

Endocrine Society
Last Updated: Jun 3, 2024
$ 209.95 Print Included Guidelines:
  • Acromegaly
  • Congenital Adrenal Hyperplasia Due to Steroid 21-Hydroxylase Deficiency
  • Cushing's Syndrome Treatment
  • Diabetes and Pregnancy
  • Diagnosis of Cushing's Syndrome
  • Evaluation and Treatment of Hypertriglyceridemia
  • Functional Hypothalamic Amenorrhea
  • Gender-Dysphoria / Gender-Incongruence
  • Glucocorticoid-Induced Adrenal Insufficiency
  • Hirsutism in Premenopausal Women
  • Hypercalcemia of Malignancy in Adults
  • Hyperglycemia in Hospitalized Adult Patients
  • Hypothalamic–Pituitary and Growth Disorders in Survivors of Childhood Cancer
  • Lipid Management in Patients with Endocrine Disorders
  • Management of Individuals with Diabetes at High Risk for Hypoglycemia
  • Menopause
  • Obesity
  • Paget's Disease of Bone
  • Pediatric Obesity
  • Pharmacological Management of Osteoporosis in Postmenopausal Women
  • Primary Adrenal Insufficiency
  • Primary Aldosteronism
  • Primary Prevention of ASCVD and T2DM in Patients at Metabolic Risk
  • Testosterone Therapy in Men With Hypogonadism
  • Treatment of Diabetes in Older Adults
  • Vitamin D for Disease Prevention
Add to Cart
Need help?